Multiomics Machine Learning to Predict Neoadjuvant Chemotherapy Outcome and Relapse of Breast Cancer
<b>Objective:</b> The aim of this study was to investigate multiomics (MO) integration with stacked-ensemble learning for predicting neoadjuvant chemotherapy (NAC) response and recurrence risk in breast cancer (BC). <b>Impact Statement:</b> This study demonstrates that a stacked-ensemble learning model integrating clinicopathologic and magnetic resonance imaging (MRI)-based intratumoral heterogeneity biomarkers effectively predicts NAC response and postoperative recurrence risk in BC patients. These findings underscore MO and machine learning's potential to optimize clinical decision-making. <b>Introduction:</b> Selecting BC patients who will benefit from NAC remains challenging. <b>Methods:</b> We retrospectively analyzed 124 BC patients receiving NAC (3 to 8 cycles) prior to mastectomy. Two radiomics signatures-RadS<sub>ET</sub> and RadS<sub>ITH</sub>-were derived from pre-NAC high-resolution dynamic MRI to track entire-tumor and intratumoral heterogeneous characteristics, respectively. These signatures were integrated with clinicopathologic indicators using stacked-ensemble learning algorithms to predict pathological complete response (pCR) and 3-year disease-free survival (DFS). <b>Results:</b> Among the 124 patients, the pCR rate was 26.6%. For pCR prediction, RadS<sub>ITH</sub> and RadS<sub>ET</sub> yielded areas under the curve (AUCs) of 0.798 and 0.770, respectively. The MO-integrated model, combining RadS<sub>ITH</sub>, RadS<sub>ET</sub>, clinical N stage, and molecular subtype, achieved a significantly higher AUC (0.917; 95% confidence interval [CI], 0.860 to 0.958; <i>P</i> < 0.05) than individual models. Postoperative recurrence occurred in 13.6% of patients. The elastic-net Cox model achieved a DFS concordance index of 0.78 (95% CI, 0.72 to 0.83) using pre-NAC variables (MO-predicted pCR, Response Evaluation Criteria in Solid Tumors response, RadS<sub>ITH</sub>), and 0.81 (95% CI, 0.76 to 0.92) with post-NAC variables (pathologic grade, pCR status, pT stage, and pN stage). <b>Conclusion:</b> The MO integration with stacked-ensemble learning effectively predicts NAC response and recurrence risk in BC.
Authors
- Xianhe Xie (ORCID: https://orcid.org/0009-0004-2254-2975)
- Lili Wang (ORCID: https://orcid.org/0000-0001-9804-886X)
- Xiaodong Zhang (ORCID: https://orcid.org/0000-0002-4789-7324)
- Ying Chen (ORCID: https://orcid.org/0009-0005-8351-6620)
- Jian Li (ORCID: https://orcid.org/0000-0002-7521-8798)
- Jing Zhang (ORCID: https://orcid.org/0000-0001-5901-5969)
- Weiwei Huang (ORCID: https://orcid.org/0000-0002-1671-699X)
Institutions
- Fujian Medical University (CN)
- Peking University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
- Peking University First Hospital (CN)
- Fujian Provincial Cancer Hospital (CN)
Publication Details
- Journal
- BME Frontiers
- Published
- 2025-12-03
- DOI
- https://doi.org/10.34133/bmef.0212
- Primary Topic
- Radiomics and Machine Learning in Medical Imaging
- Type
- article
- Field-Weighted Citation Impact
- 0.00